Imexpharm Corp Cash Flow Reinvestment Rate
Imexpharm Corp cash flow reinvestment rate. Imexpharm Corp (IMP) has a Cash Flow Reinvestment Rate of 0.30x as of June 2026, reinvesting ₫16.90 Billion (capex ₫16.90 Billion ) from operating cash flow of ₫55.75 Billion. See how financially flexible is Imexpharm Corp to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Imexpharm Corp (2019–2025)
Cash flow reinvestment rate of Imexpharm Corp from 2019 to 2025. Historical reinvestment intensity for Imexpharm Corp across 6 annual periods. Explore Imexpharm Corp (IMP) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Imexpharm Corp Cash Flow Reinvestment Rate by Year (2019–2025)
Imexpharm Corp cash flow reinvestment rate by year from 2019 to 2025. Year-by-year capital reinvestment analysis for Imexpharm Corp. For the full cash flow conversion analysis, see IMP cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (VND) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | ₫26.88 Billion | ₫54.17 Billion | ₫26.88 Billion | ▼ -52.1% |
| 2024 | 1.04x | ₫223.97 Billion | ₫216.27 Billion | ₫96.77 Billion | ▲ +31.3% |
| 2022 | 0.79x | ₫298.66 Billion | ₫378.60 Billion | ₫99.35 Billion | ▼ -37.8% |
| 2021 | 1.27x | ₫297.80 Billion | ₫234.88 Billion | ₫52.86 Billion | ▼ -52.6% |
| 2020 | 2.67x | ₫195.62 Billion | ₫73.15 Billion | ₫89.68 Billion | ▲ +9.1% |
| 2019 | 2.45x | ₫163.21 Billion | ₫66.59 Billion | ₫131.12 Billion | — |